Skip to main content
. 2025 Jun 8;13(3):2756. doi: 10.5599/admet.2756

Table 4.

Study of release profile of bisphosphonated Ca-based drug delivery systems

Carrier composition Bisphosphonate name Cumulative drug release profile Ref.
HAp Alendronate >90 % in 3 h (pH not specified) [28]
CP Alendronate >90 % in 3 h (pH 4.7) [29]
BG Alendronate >65 % in 48 h (pH 4.5) [30]
Calcium Ion Risedronate >100 % in 48 h (pH 5.5) [31]
HAp Medronate >100 % in 48 h (pH not specified) [32]
CP Medronate >100 % in 48 h (pH not specified) [32]